Skip to content

BIOCEPT, INC.: 10-K filed 2019-03-29

What BIOCEPT, INC. reported in its annual report filed 2019-03-29 (fiscal FY 2018): 43 published measures, 183 facts as tagged in accession 0001564590-19-009914.

This filing

Form
10-K (annual report)
Filed
2019-03-29
Fiscal period
fiscal FY 2018
Accession
0001564590-19-009914 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOCEPT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-12-318,750,303USD
At 2018-09-3014,551,892USD
At 2018-06-308,291,310USD
At 2018-03-3114,747,827USD
At 2017-12-317,378,906USD
At 2017-09-3011,120,215USD
At 2017-06-3014,653,193USD
At 2017-03-3117,933,413USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-12-315,707,784USD
At 2017-12-316,082,872USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-12-313,042,519USD
At 2018-09-308,938,408USD
At 2018-06-302,527,568USD
At 2018-03-318,507,714USD
At 2017-12-311,296,034USD
At 2017-09-304,026,079USD
At 2017-06-307,342,257USD
At 2017-03-3110,418,069USD
At 2016-12-31658,661USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-6,014,312USD92
2018-01-01 to 2018-12-31-24,571,601USD365
2018-07-01 to 2018-09-30-6,047,784USD92
2018-04-01 to 2018-06-30-6,153,101USD91
2018-01-01 to 2018-03-31-6,356,404USD90
2017-10-01 to 2017-12-31-5,666,573USD92
2017-01-01 to 2017-12-31-21,613,737USD365
2017-07-01 to 2017-09-30-5,821,306USD92
2017-04-01 to 2017-06-30-5,693,151USD91
2017-01-01 to 2017-03-31-4,432,707USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-22,355,218USD365
2017-01-01 to 2017-12-31-19,650,726USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-12-31145,253USD365
2017-01-01 to 2017-12-311,400,180USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-10-01 to 2018-12-31859,526USD92
2018-01-01 to 2018-12-313,250,298USD365
2018-07-01 to 2018-09-30761,591USD92
2018-04-01 to 2018-06-30822,238USD91
2018-01-01 to 2018-03-31806,943USD90
2017-10-01 to 2017-12-31995,226USD92
2017-01-01 to 2017-12-315,068,663USD365
2017-07-01 to 2017-09-301,111,411USD92
2017-04-01 to 2017-06-301,278,961USD91
2017-01-01 to 2017-03-311,683,065USD90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-12-3123,777,233USD365
2017-01-01 to 2017-12-3118,588,185USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-145,253USD365
2017-01-01 to 2017-12-31-1,400,180USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-12-31-220,457,578USD
At 2017-12-31-195,249,607USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-10-01 to 2018-12-314,209,221shares92
2018-01-01 to 2018-12-312,798,243shares365
2018-07-01 to 2018-09-302,767,440shares92
2018-04-01 to 2018-06-302,280,115shares91
2018-01-01 to 2018-03-311,911,282shares90
2017-10-01 to 2017-12-311,058,055shares92
2017-01-01 to 2017-12-31916,599shares365
2017-07-01 to 2017-09-30995,254shares92
2017-04-01 to 2017-06-30901,007shares91
2017-01-01 to 2017-03-31707,389shares90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-10-01 to 2018-12-314,209,221shares92
2018-01-01 to 2018-12-312,798,243shares365
2018-07-01 to 2018-09-302,759,614shares92
2018-04-01 to 2018-06-302,280,115shares91
2018-01-01 to 2018-03-311,911,282shares90
2017-10-01 to 2017-12-311,058,055shares92
2017-01-01 to 2017-12-31916,599shares365
2017-07-01 to 2017-09-30995,254shares92
2017-04-01 to 2017-06-30901,007shares91
2017-01-01 to 2017-03-31707,389shares90

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-1.43USD/shares92
2018-01-01 to 2018-12-31-9.01USD/shares365
2018-07-01 to 2018-09-30-2.42USD/shares92
2018-04-01 to 2018-06-30-2.7USD/shares91
2018-01-01 to 2018-03-31-3.33USD/shares90
2017-10-01 to 2017-12-31-5.36USD/shares92
2017-01-01 to 2017-12-31-23.58USD/shares365
2017-07-01 to 2017-09-30-5.85USD/shares92
2017-04-01 to 2017-06-30-6.32USD/shares91
2017-01-01 to 2017-03-31-6.27USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-1.43USD/shares92
2018-01-01 to 2018-12-31-9.01USD/shares365
2018-07-01 to 2018-09-30-2.42USD/shares92
2018-04-01 to 2018-06-30-2.7USD/shares91
2018-01-01 to 2018-03-31-3.33USD/shares90
2017-10-01 to 2017-12-31-5.36USD/shares92
2017-01-01 to 2017-12-31-23.58USD/shares365
2017-07-01 to 2017-09-30-5.85USD/shares92
2017-04-01 to 2017-06-30-6.32USD/shares91
2017-01-01 to 2017-03-31-6.27USD/shares90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-01-01 to 2018-12-311,886USD365
2017-01-01 to 2017-12-317,624USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-12-312,739,422USD
At 2017-12-313,123,567USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-12-31623,412USD365
2017-01-01 to 2017-12-311,247,481USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-5,938,161USD92
2018-01-01 to 2018-12-31-24,258,739USD365
2018-07-01 to 2018-09-30-6,007,983USD92
2018-04-01 to 2018-06-30-6,038,862USD91
2018-01-01 to 2018-03-31-6,273,733USD90
2017-10-01 to 2017-12-31-5,566,521USD92
2017-01-01 to 2017-12-31-21,174,706USD365
2017-07-01 to 2017-09-30-5,742,964USD92
2017-04-01 to 2017-06-30-5,476,628USD91
2017-01-01 to 2017-03-31-4,388,593USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-12-316,010,881USD
At 2017-12-314,255,339USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-01-01 to 2018-12-31310,976USD365
2017-01-01 to 2017-12-31482,623USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-12-314,609,647USD
At 2017-12-314,661,345USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-12-312,039,718USD
At 2017-12-311,269,953USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-12-311,574,325USD
At 2017-12-311,193,426USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2018-12-31587,222USD
At 2017-12-31498,702USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2018-10-01 to 2018-12-312,435,262USD92
2018-01-01 to 2018-12-3110,051,735USD365
2018-07-01 to 2018-09-302,481,916USD92
2018-04-01 to 2018-06-302,699,671USD91
2018-01-01 to 2018-03-312,434,886USD90
2017-10-01 to 2017-12-312,359,909USD92
2017-01-01 to 2017-12-319,345,122USD365
2017-07-01 to 2017-09-302,487,054USD92
2017-04-01 to 2017-06-302,368,705USD91
2017-01-01 to 2017-03-312,129,454USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-10-01 to 2018-12-311,288,957USD92
2018-01-01 to 2018-12-314,468,572USD365
2018-07-01 to 2018-09-301,089,746USD92
2018-04-01 to 2018-06-301,019,285USD91
2018-01-01 to 2018-03-311,070,584USD90
2017-10-01 to 2017-12-31908,800USD92
2017-01-01 to 2017-12-313,364,747USD365
2017-07-01 to 2017-09-30856,698USD92
2017-04-01 to 2017-06-30841,991USD91
2017-01-01 to 2017-03-31757,258USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-12-314,629,174shares
At 2017-12-311,181,179shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-12-317,674,150USD
At 2017-12-317,477,664USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-12-314,934,728USD
At 2017-12-314,354,097USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-12-311,928,393USD
At 2017-12-311,752,363USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2018-12-31425,961USD
At 2017-12-31416,600USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-24,569,715USD365
2017-01-01 to 2017-12-31-21,606,113USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-6,014,312USD92
2018-01-01 to 2018-12-31-25,207,971USD365
2018-07-01 to 2018-09-30-6,684,154USD92
2018-04-01 to 2018-06-30-6,153,101USD91
2018-01-01 to 2018-03-31-6,356,404USD90
2017-01-01 to 2017-12-31-21,613,737USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-10-01 to 2018-12-311,632,670USD92
2018-01-01 to 2018-12-317,074,024USD365
2018-07-01 to 2018-09-301,793,720USD92
2018-04-01 to 2018-06-301,708,970USD91
2018-01-01 to 2018-03-311,938,664USD90
2017-10-01 to 2017-12-311,650,097USD92
2017-01-01 to 2017-12-317,189,529USD365
2017-07-01 to 2017-09-301,834,771USD92
2017-04-01 to 2017-06-301,798,026USD91
2017-01-01 to 2017-03-311,906,635USD90

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-01-01 to 2017-12-3151,216USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-310,976USD365
2017-01-01 to 2017-12-31-431,407USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2018-01-01 to 2018-12-311,886USD365
2017-01-01 to 2017-12-317,624USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-12-31605,485USD365
2017-01-01 to 2017-12-31358,471USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2018-01-01 to 2018-12-314,517USD365
2017-01-01 to 2017-12-315,273USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-09-19 to 2018-09-202,500,000USD2
2018-08-12 to 2018-08-1311,600,000USD2
2017-08-10 to 2017-08-112,200,000USD2

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-12-31380,899USD365
2017-01-01 to 2017-12-311,064,457USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-12-3150,021USD365
2017-01-01 to 2017-12-31-100,875USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-12-31601,872USD365
2017-01-01 to 2017-12-31349,932USD365

Inspect the source

Entity
BIOCEPT, INC. / CIK 0001044378
Captured
SEC response SHA-256
e2cd33a1599dddaf1c1158b0c135422459c9498a550077875151b7dd6db64b15

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001044378.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))